Holen Sie sich die Stockscreener-App
3.77
0.79%
-0.03
Handel nachbörslich:
3.80
0.03
+0.80%
Schlusskurs vom Vortag:
$3.80
Offen:
$3.87
24-Stunden-Volumen:
96,577
Relative Volume:
0.29
Marktkapitalisierung:
$1.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-53.12M
KGV:
-0.0347
EPS:
-108.8
Netto-Cashflow:
$-15.86M
1W Leistung:
-16.78%
1M Leistung:
-10.02%
6M Leistung:
-90.94%
1J Leistung:
-99.29%
1-Tages-Spanne:
$3.65
$3.87
1-Wochen-Bereich:
$3.16
$4.21
52-Wochen-Spanne:
$3.16
$656.88
Onconetix Inc Stock (ONCO) Company Profile
Firmenname
Onconetix Inc
Sektor
Branche
Telefon
513-620-4101
Adresse
201 E. FIFTH STREET, CINCINNATI
Vergleichen Sie ONCO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
3.77 | 2.36M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Onconetix Inc Aktie (ONCO) Neueste Nachrichten
Onconetix Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - jammulinksnews.com
What drives Onconetix Inc. stock priceSuperior profit margins - jammulinksnews.com
What makes Onconetix Inc. stock price move sharplyDaily Gain Forecast - Newser
What analysts say about Onconetix Inc. stockPhenomenal wealth increase - printweek.in
Is Onconetix Inc. a good long term investmentSuperior returns - PrintWeekIndia
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ONCO, WAT, XAGE on Behalf of Shareholders - The Malaysian Reserve
Halper Sadeh investigates Onconetix, Waters, and Longevity Health Holdings mergers. - AInvest
Can Onconetix Inc. stock recover from recent declineFree Insider Trading Tips - Newser
Onconetix Announces Merger with Ocuvex Therapeutics - The Globe and Mail
Big Moves And Bigger Questions For Biotech And Tech Stocks - Finimize
Onconetix Shares Plunge 22.52% Amid Dilutive Merger - AInvest
Onconetix, Ocuvex execute definitive merger agreement - TipRanks
ONCO Stock on the Rise: A Promising Investment - investchronicle.com
Onconetix Shares Collapse 19% as Merger Uncertainties Collide with Legal Risks - AInvest
Onconetix Merger: Navigating Legal Risks and Market Volatility - AInvest
ONCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Onconetix, Inc. Is Fair to Shareholders - The Globe and Mail
Onconetix Crashes 18% as Merger with Ocuvex Sparks Dilution Fears and Liquidity Concerns - AInvest
Onconetix to buy privately held Ocuvex Therapeutics (ONCO) - Seeking Alpha
Onconetix To Merge With Ocuvex Therapeutics - Nasdaq
Onconetix Soars 13.69% on Ocuvex Merger Announcement - AInvest
Onconetix and Ocuvex Therapeutics announce definitive merger agreement By Investing.com - Investing.com Nigeria
Onconetix and Ocuvex Therapeutics announce definitive merger agreement - Investing.com Australia
Onconetix, Inc. and Ocuvex Therapeutics, Inc. Announce Definitive Merger Agreement - Nasdaq
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement - GlobeNewswire
Major Biotech Merger: Ocuvex Takes 90% Control of Onconetix to Advance Ophthalmic Pipeline - Stock Titan
How Onconetix Inc. stock performs during market volatilitySafety First Trading Signals - Newser
Why Onconetix Inc. stock attracts strong analyst attentionFree Real-Time Stock Data - Newser
Onconetix Secures Nasdaq Listing with Panel Decision - TipRanks
Onconetix receives positive decision by Nasdaq Hearings Panel - TipRanks
Onconetix regains Nasdaq compliance after filing Q1 report - Investing.com
Onconetix, Inc. Announces Positive Decision By Nasdaq Hearings Panel - MarketScreener
Finanzdaten der Onconetix Inc-Aktie (ONCO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):